Product Information
AUSTEDO 9 MG TABLET is a brand product labeled by Teva Neuroscience, Inc., priced at $93.9598 per EA under NDC 68546017160. Its NADAC has been published 314 times since Aug 19, 2020.
FDA first approved this application on Apr 3, 2017.
Strength
9 mg/1
Manufacturer
Teva Neuroscience, Inc.NDC
68546017160
Classification
Brand
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DEUTETRABENAZINEApproval Type
New Drug (NDA)
FDA Application
NDA208082FDA Approved
4/3/2017
On Market Since
4/12/2017
Price Statistics
The NADAC for AUSTEDO 9 MG TABLET has been published 314 times since Aug 19, 2020, and over the history we have for it it has risen 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $93.9598 per EA |
|---|---|
| All-time high | $94.1649 (Jul 15, 2026) |
| All-time low | $69.7828 (Aug 19, 2020) |
| 52-week high | $94.1649 |
| 52-week low | $89.0809 |
| Median price | $85.1603 |
| Average price | $83.4057 |
| Largest weekly change | +7.9% (Jan 12, 2022) |
| Weeks tracked | 314 |
| Tracking since | Aug 19, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Deutetrabenazine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AUSTEDO 9 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AUSTEDO 9 MG TABLET, manufactured by Teva Neuroscience, Inc., is $93.9598 per EA (NDC 68546017160), effective Aug 19, 2026.
How has the price of AUSTEDO 9 MG TABLET changed over time?
Over the history we have for it, the NADAC for AUSTEDO 9 MG TABLET has risen 34.6%. It has been tracked across 314 weekly CMS publications since Aug 19, 2020.
What are the highest and lowest recorded NADAC prices for AUSTEDO 9 MG TABLET?
Since Aug 19, 2020, the NADAC for AUSTEDO 9 MG TABLET has ranged from a low of $69.7828 (Aug 19, 2020) to a high of $94.1649 (Jul 15, 2026), with a median of $85.1603 per EA.
Are there cheaper alternatives to AUSTEDO 9 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of AUSTEDO 9 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AUSTEDO 9 MG TABLET?
AUSTEDO 9 MG TABLET (NDC 68546017160) is labeled by Teva Neuroscience, Inc., and CMS classifies it as a brand product.